"The pharmaceuticals group Shire rose 61.5p to £10.60 on continuing takeover hopes. Its US rival Pfizer had been tipped as one potential predator, and yesterday analysts at the Swiss bank UBS suggested AstraZeneca, up 41p to £17.89, could also be interested."
http://www.guardian.co.uk/business/2008/mar/19/marketforces
Wednesday, March 19, 2008
SHP
